About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Observational Registry Study of Renal Transplant Patients

Observational Registry Study of Renal Transplant Patients

NCT01284257·8 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Novartis Pharmaceuticals

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

18 years of age or older.
The de novo recipient of a cadaveric or living donor kidney transplant, within two weeks of transplantation.
Receiving mycophenolic acid (MPA) therapy of either myfortic® or CellCept®.
Able to provide informed consent.
Able to self-administer the ITAS compliance instrument (6 questions).

You may not be if

The recipient of multiple organ grafts or prior non-kidney graft.
Enrolled or plans to enroll in an investigational clinical trial.
Not likely to have up to 5 year follow-up data available for this study.

The record

StatusWithdrawn

PhaseNo phase

Taking part0

StartedJun 2007

UpdatedFeb 27, 2017

Conditions

Kidney Transplant

Where8

San Francisco investigational site
San Francisco, California, United States
Denver Investigational site
Denver, Colorado, United States
Springfield investigational site
Springfield, Massachusetts, United States